A low-cost, disposable patient-controlled analgesia device was tested using a computer-controlled, automated testing station designed to simulate clinical use. Five devices were tested and delivered a mean bolus dose size of 95% of nominal, although one device achieved only 85% of nominal. Delivery was lowest immediately following an eight-hour interval during which no demands were made. Further development and evaluation of this interesting device is warranted.
Patient-controlled analgesia (PCA), now a well established form of postoperative pain relief, is generally administered by microprocessor-controlled infusion devices. These high-technology devices necessitate a large initial capital outlay, which may limit availability of the technique in some centres. A lowcost pump would therefore be an attractive alternative, and a disposable, non-electronic PCA device has been developed to meet this need. 1 Evaluation of PCA pumps has often been superficial, occasionally resulting in potentially hazardous situations during clinical use. 2 Many pumps have been marketed without a single publication attesting their safety or utility. J The aim of this study was to evaluate a new disposable PCA device, by assessment of the accuracy of delivered bolus volumes, using an automated system. The aim was to test five devices each for three days of continuous use in a pattern designed to simulate clinical use and incorporating a range of demand rates similar to those encountered postoperatively.
DESCRIPTION OF PUMP
The Go Medical PCI (Patient Controlled Injector) is a low-cost, non-electronic disposable PCA device manufactured in Australia (Go Medical Industries Pty Ltd, Subiaco, WA 6008). The device ( Figure 1 ) consists 'FR.CAnaes., Research Fellow. tPh.D., Grad. Dip. Comp., Principal Hospital Scientist. t:V1.D., FR.CAnaes., FA.N.Z.CA., Senior Staff Specialiq. ~Ph.D., (;rad.Dip.AppI.Stat., Principal Hospital Scientist. of a spring-loaded delivery syringe (PCI syringe: 7), having a nominal volume of 0.5 m!. The patient is able to self-administer this volume (containing, for example, 1 mg of morphine, when the manufacturer's recommended dilution is used), by depressing the patient demand button (6) attached to the pcr syringe. The analgesic bolus is delivered by positive displacement into the patient's intravenous line via a one-way valve (8) and hydrophobic ("air-venting") filter (2) , which functions as a particulate matter filter as well as preventing air embolism. A reservoir syringe (4) is connected to the PCI syringe via fine-bore "flowcontrol" tubing (5) . After the patient demand buttori has been released, the plunger of the PCI syringe is returned by a simple spring loaded mechanism. This creates a pressure difference between the reservoir and delivery syringes, which causes the latter to fill but at a rate limited by the flow-control tubing. The high resistance of this tubing also minimises back flow into the reservoir syringe when the demand button is pressed. The nominal filling time of the PCI syringe is six minutes, thus providing a lock-out interval. If the button is pressed before this time, the patient will receive a reduced dose of solution as the PCI syringe will be incompletely filled. Rather than simply replacing the reservoir syringe when it is empty, the manufacturer has chosen to incorporate a Refill Port (1), through which the reservoir syringe can be refilled. A second air-venting filter and a one-way valve are also incorporated at this point in the system. The reservoir syringe can be contained within a lockable plastic container, to provide an element of security, Before initiating PCA the system is primed with drug solution through the reservoir port (3). However, because of the fine bore of the flow-control tubing, the manufacturer recommends the application of negative pressure at the PCI one-way valve using a syringe and three-way tap to speed the process of priming.
METHODS
The system used to test these pumps was a modification of a previously developed computer-controlled system. 4 Activation of bolus requests was made automatically in a pattern designed to simulate requests made by a postoperative patient: in each one hour interval from zero to six demands were made ( Table  1) . The system was interfaced to a set of electrically operated pneumatic solenoid valves which delivered piped compressed air, via a regulator, to a "pneumatic thumb" which activated the PCA device. The "thumb" consisted of a 50 ml syringe, with the addition of an elastic return mechanism to return the plunger after completion of each bolus activation. This syringe and the PCA device were held in a rigid frame to prevent unwanted movement during activation. The pump delivered solution (5070 glucose) via flexible tubing and a long needle to a measuring cylinder whose weight was determined using an electronic balance (Mettler PM2000). The cumulative weight of boluses was updated to disk by the computer (Toshiba TlOOO Laptop) at hourly intervals. Delivered volume was calculated from the measured weight and the density of 5% glucose at the temperature of the laboratory (26 QC). The nominal hourly volume, according to the patient-request-profile, was also calculated. Mean bolus size for each hour was calculated by dividing the hourly delivery by the number of demands made in each hour.
Five devices were each tested for three days: the reservoir syringe of each device was refilled at the end of 24 and 48 hours, as would be the case in clinical use.
RESULTS
Priming of the devices tested was found to be awkward and time-consuming. Considerable care was required to prevent air from becoming entrapped within the pcr syringe during priming. Preliminary tests showed that air within the system resulted in reduced bolus size.
The mean bolus size (for all five pumps over the three days) was 0.48 ml or 95% of the nominal 0.5 ml. The cumulative volume delivered over the 24 hour patientrequest profile is shown for a typical device (Figure 2 ). There was little variation between four of the five devices. The other device delivered a mean of only 85% of nominal. Table 2 shows the mean volume delivered by each device (as a percentage of nominal delivery), and the largest and smallest volumes, representing the worst overand under-delivery over three days. There was a reduction in size of the first bolus (to a mean of 88%) following the eight hour period in which no demands were made (Figure 3 ). There was a trend for delivered volumes to decrease over time (98%,94% and 91 % of nominal on days 1, 2 and 3 respectively). Mean, minimum and maximum hourly delivery over three days, as a percentage of nominal volume, for the five devices tested 
DISCUSSION
This study was undertaken to evaluate a new disposable device in a more precise manner than has generally been undertaken before PCA devices have been introduced. J The Go Medical PCI was found to deliver consistent bolus dose sizes. Four of the five devices tested delivered very close to the nominal bolus volume. There was a slight reduction in delivery over time, but this is unlikely to be of clinical significance.
We did not formally assess the duration of the lockout interval in this study. The patient-demand profile was chosen to include the range of demands that might be encountered in clinical practice and when six demands per hour were made the device functioned well. Other than a nominal "filling time", the manufacturer does not make any claim as to the nominal performance of the device at inter-demand intervals of less than the nominal filling time.
The use of disposable, non-electronic PCA devices may have advantages other than the saving in capital outlay. These devices are portable, do not require a source of electricity and are less cumbersome than their non-disposable counterparts. They are relatively simple devices, which are not subject to programming errors or electronic malfunctions. 5 Such devices do, however, suffer from the drawback of lack of flexibility; for example, the lock-out interval cannot be changed, change of bolus dose size requires the filling of a new pump and there is no facility for the addition of a background infusion. They provide only a coarse visual display of analgesic drug usage and no display of number of unsuccessful demands. There are no alarms to warn of empty reservoir or occlusion, for example. However, another disposable PCA device with some of the same limitations has been evaluated in the clinical setting, 1.6 and found to perform acceptably.
Security of disposable PCA devices is problematical. Any system to make them secure and tamper-resistant may make them unwieldy and negate the advantages of their small size and portability. The security methods used in this device are rudimentary and would probably be relatively ineffective. If security of the opioid syringe is considered to be an important issue then this would not be the device to use.
Before introducing the Go Medical PCI into general clinical use a simpler priming method needs to be developed. However, the system is evolving: it is easy to envisage a place in the future for this type of device in the management of postoperative pain. Clinical studies would be required to further evaluate its use.
